Lassa Fever 2016 Outbreak in Plateau State, Nigeria-The Changing Epidemiology and Clinical Presentation
- PMID: 30211144
- PMCID: PMC6123362
- DOI: 10.3389/fpubh.2018.00232
Lassa Fever 2016 Outbreak in Plateau State, Nigeria-The Changing Epidemiology and Clinical Presentation
Abstract
Lassa fever (LF) outbreaks in Nigeria mostly occur in rural areas and during the dry season, peaking between December through February. Fever is a cardinal presenting feature among the myriad manifestations of LF. Thirty four patients with clinical diagnosis of LF were analyzed. However, only 11 (32%) LASV infections were confirmed by RT-PCR. The 2016 LF outbreak showed a preferential urban occurrence and a high case fatality. Fever (≥38°C) was not detected in over a fourth of the patients at the time of examination. Bleeding diathesis was the most common presentation while abdominal pain and headache were present in more than half of the confirmed cases. Changes in the geographical distribution and clinical presentation may have implications for disease control efforts and the risk of transmission, both locally and internationally. In order to guide interventions, public health authorities should be aware that the epidemic patterns may be changing.
Keywords: Nigeria; clinical presentation; epidemiology; fever; lassa.
Figures
Similar articles
-
Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.BMC Infect Dis. 2021 Feb 5;21(1):149. doi: 10.1186/s12879-021-05837-x. BMC Infect Dis. 2021. PMID: 33546623 Free PMC article.
-
Lassa fever outbreak in adolescents in North Central Nigeria: report of cases.J Virus Erad. 2018 Oct 1;4(4):225-227. doi: 10.1016/S2055-6640(20)30306-X. J Virus Erad. 2018. PMID: 30515301 Free PMC article.
-
Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).Int J Infect Dis. 2013 Nov;17(11):e1011-6. doi: 10.1016/j.ijid.2013.05.015. Epub 2013 Jul 17. Int J Infect Dis. 2013. PMID: 23871405
-
Current research for a vaccine against Lassa hemorrhagic fever virus.Drug Des Devel Ther. 2018 Aug 14;12:2519-2527. doi: 10.2147/DDDT.S147276. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30147299 Free PMC article. Review.
-
Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review.Ther Adv Infect Dis. 2021 Nov 29;8:20499361211058252. doi: 10.1177/20499361211058252. eCollection 2021 Jan-Dec. Ther Adv Infect Dis. 2021. PMID: 34868582 Free PMC article. Review.
Cited by
-
Lassa virus diversity and feasibility for universal prophylactic vaccine.F1000Res. 2019 Jan 31;8:F1000 Faculty Rev-134. doi: 10.12688/f1000research.16989.1. eCollection 2019. F1000Res. 2019. PMID: 30774934 Free PMC article. Review.
-
CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model.PLoS Pathog. 2022 May 23;18(5):e1010557. doi: 10.1371/journal.ppat.1010557. eCollection 2022 May. PLoS Pathog. 2022. PMID: 35605008 Free PMC article.
-
Double stigma: a cross-sectional study of Lassa patients with hearing loss in North Central Nigeria.Front Public Health. 2024 Jul 15;12:1395939. doi: 10.3389/fpubh.2024.1395939. eCollection 2024. Front Public Health. 2024. PMID: 39076422 Free PMC article.
-
The Importance of Lassa Fever and Its Disease Management in West Africa.Viruses. 2024 Feb 7;16(2):266. doi: 10.3390/v16020266. Viruses. 2024. PMID: 38400041 Free PMC article. Review.
-
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever.Emerg Infect Dis. 2020 Nov;26(11):2625-2637. doi: 10.3201/eid2611.191694. Emerg Infect Dis. 2020. PMID: 33079033 Free PMC article.
References
-
- McCormick J. Lassa fever. In: Saluzzo J, Dodet B. editors. Emergence and Control of Rodent-Borne Viral Diseases. Paris: Elsevier; (1999). p. 177–95.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources